Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice - PubMed (original) (raw)

Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice

Jun-Qi Yang et al. J Immunol. 2003.

Abstract

NK T (NKT) cells expressing the invariant Valpha14-Jalpha18 TCR alpha-chain recognize glycolipid Ags such as alpha-galactosylceramide (alpha-GalCer) presented by the MHC class I-like molecule CD1d. Upon activation by alpha-GalCer, invariant NKT cells secrete multiple cytokines and confer protection in certain immune-mediated disorders. Here we have investigated the role of NKT cells in the development of inflammatory dermatitis in MRL-lpr/lpr mice, which shares features with lupus in humans. Our results show that the numbers Sand functions of NKT (TCRbeta(+)CD1d/alpha-GalCer tetramer(+)) cells, particularly of the NK1.1(-) subset, are reduced in MRL-lpr/lpr mice compared with MRL-fas/fas and/or nonautoimmune C3H/Hej and BALB/c mice. Repeated treatments with alpha-GalCer result in the expansion of NKT cells and alleviate dermatitis in MRL-lpr/lpr mice. Our results indicate that NKT cell deficiency can be corrected by repeated alpha-GalCer treatment and that NKT cells may play a protective role in inflammatory dermatitis of lupus-prone mice.

PubMed Disclaimer

Cited by

CD3+CD56+ T Lymphocytes Are Associated With ER Stress and Inflammasome Activation in Type 1 Diabetes.
Huang YN, Lin WD, Su PH, Bau DT, Tsai FJ, Huang CC, Wang CH. Huang YN, et al. In Vivo. 2022 Sep-Oct;36(5):2083-2091. doi: 10.21873/invivo.12934. In Vivo. 2022. PMID: 36099092 Free PMC article. Retracted.
Polymeric dexamethasone prodrugs attenuate lupus nephritis in MRL/lpr mice with reduced glucocorticoid toxicity.
Zhao Z, Jiang H, Xu X, Jia Z, Ren R, Foster KW, Wei X, Chen N, Goldring SR, Crow MK, Wang D. Zhao Z, et al. Nanomedicine. 2022 Aug;44:102579. doi: 10.1016/j.nano.2022.102579. Epub 2022 Jun 26. Nanomedicine. 2022. PMID: 35768036 Free PMC article.
Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
Hsu CY, Chueh YS, Kuo ML, Lee PT, Hsiao HS, Huang JL, Lin SJ. Hsu CY, et al. PLoS One. 2021 Dec 22;16(12):e0261727. doi: 10.1371/journal.pone.0261727. eCollection 2021. PLoS One. 2021. PMID: 34936686 Free PMC article.
Fas mutation reduces obesity by increasing IL-4 and IL-10 expression and promoting white adipose tissue browning.
Choi EW, Lee M, Song JW, Kim K, Lee J, Yang J, Lee SH, Kim IY, Choi JH, Seong JK. Choi EW, et al. Sci Rep. 2020 Jul 20;10(1):12001. doi: 10.1038/s41598-020-68971-7. Sci Rep. 2020. PMID: 32686763 Free PMC article.
Hyaluronic Acid Synthesis Contributes to Tissue Damage in Systemic Lupus Erythematosus.
Suarez-Fueyo A, Tsokos MG, Kwok SK, Maeda K, Katsuyama E, Lapchak PH, Tsokos GC. Suarez-Fueyo A, et al. Front Immunol. 2019 Sep 13;10:2172. doi: 10.3389/fimmu.2019.02172. eCollection 2019. Front Immunol. 2019. PMID: 31572382 Free PMC article.

Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice - PubMed (original) (raw)